The License Agreement grants the Company exclusive, worldwide rights to research, develop, make, use, or sell Licensed Products and/or Licensed Processes (as defined in the License Agreement) based u…
Provectus Biopharmaceuticals, Inc. Customers
No clients on recordNo downstream customers found in our database for Provectus Biopharmaceuticals, Inc..
Provectus Biopharmaceuticals, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
PVCT-DEBT
Debt stack $2.8M
90%
Market cache reports total debt of $2.8M.
PVCT-DEBT-11958
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
PVCT-DEBT-11957
Warrants outstanding: 4700000
90%
xbrl warrant detail from xbrl 2021-12-31.
Provectus Biopharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Provectus Biopharmaceuticals, Inc..
Provectus Biopharmaceuticals, Inc. Ownership
Holder
Name
Confidence
Evidence
PVCT-OWNER-HOME-FEDERAL-BANK-OF-TENNESSEE
HOME FEDERAL BANK OF TENNESSEE
90%
13F overlay lists HOME FEDERAL BANK OF TENNESSEE as top holder; 6 tracked holders.
Provectus Biopharmaceuticals, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
Provectus Biopharmaceuticals, Inc. Supply Chain Intel